MoneyWeek magazine
-
Fuller’s outperforms in a tough market – here's why it is worth buyingPub group Fuller’s continues to outperform despite headwinds in the hospitality sector. Should you buy its shares?
By Rupert Hargreaves Published
-
Hiscox is a safe bet in insurance – how to play its sharesHiscox's strategy has allowed it to generate consistent profits, and the stock is very reasonably valued. Here's how to play the share price
By Dr Matthew Partridge Published
-
Will AI really wipe out all our jobs?How worried should we be about AI? Technological developments have always sparked fears of mass unemployment – but are those fears overdone?
By Stuart Watkins Published
-
High-quality and profitable companies in emerging marketsOpinion Three emerging market stocks, picked by Mark Hammonds, fund manager for the Guinness Emerging Markets Equity Income Fund
By Mark Hammonds Published
Opinion -
Can Andy Burnham’s Manchesterism work for Britain?Andy Burnham wants to spread his “Manchesterism” to the rest of the country. But what is it, and will it work?
By Simon Wilson Published
-
The best properties for sale with swimming poolsEight of the best properties for sale with swimming pools – from a New England-style house in Kent to a converted grain store in Warwickshire with a natural swimming pool.
By Natasha Langan Published
-
'Investors shouldn't sell Segro for short-term gain'Prologis's bid for Segro marks another milestone in the London Stock Exchange's decline. Its departure would be a dismal outcome for the UK, says Max King
By Max King Published
-
Biotech's future looks bright – the best investments to buyBiotechnology companies are coming out of a dark period for the industry. Why has the tide turned, and is now a good time to buy in?
By David Prosser Published
-
The MoneyWeek ETF portfolio – July 2026 updateWe're updating our ETF portfolio – the outlook for the Middle East is still uncertain, but it rarely pays to sit on the sidelines indefinitely.
By Cris Sholto Heaton Published
